Nanjing Leads Biolabs Co., Ltd. (HKG:9887)
Hong Kong · Delayed Price · Currency is HKD 85.45
-8.40 (-8.95%)
Apr 17, 2026, 3:30 PM HKT
Nanjing Leads Biolabs Market Cap
Nanjing Leads Biolabs has a market cap or net worth of 18.54 billion as of April 16, 2026.
Market Cap
18.54B
Enterprise Value
17.13B
Revenue
197.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
85.45
Market Cap Chart
Since July 25, 2025, Nanjing Leads Biolabs's market cap has increased from 12.97B to 18.54B, an increase of 42.90%. That is a compound annual growth rate of 63.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 18.54B | 82.78% |
| Dec 31, 2025 | 10.14B | -21.82% |
| Jul 25, 2025 | 12.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Bao Pharmaceuticals | 29.34B |
| Duality Biotherapeutics | 28.65B |
| Genscript Biotech | 27.79B |
| TransThera Sciences (Nanjing) | 27.75B |
| Keymed Biosciences | 23.36B |
| Ascentage Pharma Group International | 19.54B |
| Zai Lab | 19.38B |
| Ascletis Pharma | 18.37B |